ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director

November 26, 1993

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

NCAB Votes to Bring Organ Systems Coordinating Center Into NCI, Disperse Entire Grants Portfolio

February 12, 1988